Dr. Satya Prakash Gupta
My Social Links

Dr. Satya Prakash Gupta

Professor
Meerut Institute of Engineering and Technology, India

Highest Degree
Ph.D. in Pharmaceutical Technology from Meerut Institute of Engineering and Technology, Meerut, India

Share this Profile

Area of Interest:

Chemistry
100%
Medicinal Chemistry
62%
Pharmaceutical Chemistry
90%
Computational Chemistry
75%
Organic Chemistry
55%

Research Publications in Numbers

Books
0
Chapters
0
Articles
0
Abstracts
0

Selected Publications

  1. Shaik, B., S.P. Gupta and S. Sharma, 2019. Quantitative structure-activity relationship and docking studies on a series of H+/K+-ATPase inhibitors. Lett. Drug Des. Discov., Vol. 16, (In Press). 10.2174/1570178616666190222153819.
    CrossRef  |  Direct Link  |  
  2. Gupta, S.P., 2019. Roles of fluorine in drug design and drug action. Lett. Drug Des. Discov., Vol. 16, (In Press). 10.2174/1570180816666190130154726.
    CrossRef  |  Direct Link  |  
  3. Bhardwaj, M., V.M. Patil, R. Dhiman, S.P. Gupta and N. Masand, 2019. Anti-acetylcholinesterase derivatives: A privileged structural framework in drug discovery to treat Alzheimer’s disease. Curr. Enzym. Inhibn., Vol. 15, (In Press). 10.2174/1573407215666190111150241.
    CrossRef  |  Direct Link  |  
  4. Balasubramanian, K. and S.P. Gupta, 2019. Quantum molecular dynamics, topological, group theoretical and graph theoretical studies of protein-protein interactions. Curr. Topics Med. Chem., Vol. 19, (In Press). 10.2174/1568026619666190304152704.
    CrossRef  |  Direct Link  |  
  5. Arya, R., S.P. Gupta, S. Paliwal, S. Sharma, K. Madan and M. Chauhan, 2019. Pharmacophore modeling and docking studies to investigate potential leads for the development of β-secretase APP cleavage enzyme-1 (BACE-1) inhibitors. Lett. Drug Des. Discov., Vol. 16, (In Press). 10.2174/1570180815666181023110736.
    CrossRef  |  Direct Link  |  
  6. Arya, R., S.P. Gupta, S. Paliwal, S. Kesar, A. Mishra and Y.S. Prabhakar, 2019. QSAR and molecular modeling studies on a series of pyrrolidine analogs acting as BACE-1 inhibitors. Lett. Drug Des. Discov., Vol. 16, (In Press). 10.2174/1570180815666180627124422.
    CrossRef  |  Direct Link  |  
  7. Shaik, B., S.P. Gupta, T. Zafar and K. Anita, 2018. QSAR and molecular docking studies on a series of 1-amino-5H-pyrido [4, 3-b] indol-4-carboxamides acting as janus kinase 2 (JAK2) inhibitors. Lett. Drug Des. Discov., 15: 169-180.
    CrossRef  |  Direct Link  |  
  8. Patil, V.M., N. Masand and S.P. Gupta, 2018. Zika Virus Polymerase: Structure, Function and Inhibitors. In: Viral Polymerases: Structure, Functions and Roles as Antiviral Drug Targets, Gupta, S.P. (Ed.). Academic Press, London, pp: 357-385.
  9. Patil, V.M. and S.P. Gupta, 2018. Structural flexibility in HCV NS5B polymerase and development of anti-HCV drugs. Curr. Chem. Biol., 12: 65-87.
  10. Masand, N., S.P. Gupta and R.L. Khosa, 2018. N-substituted aryl sulphonamides as potential anti-Alzheimer’s agents: Design, synthesis and biological evaluation. Curr. Comput.-Aided Drug Des., 14: 338-348.
    CrossRef  |  Direct Link  |  
  11. Martis, E.A.F., B. Joseph, S.P. Gupta, E.C. Coutinho, I. Hdoufane, I. Bjij and D. Cherqaoui, 2018. Flexibility of important HIV-1 targets and in silico design of anti-HIV drugs. Curr. Chem. Biol., 12: 23-39.
    CrossRef  |  Direct Link  |  
  12. Gupta, S.P., 2018. Roles of metal ions in human health. MOJ Biorg. Org. Chem., 2: 221-224.
  13. Gupta, S.P., 2018. Protein flexibility: A challenging issue of drug discovery. Curr. Chem. Biol., 12: 3-13.
    CrossRef  |  Direct Link  |  
  14. Gupta, S.P. and K. Balasubramanian, 2018. Studies on HIV-1 Polymerase and its Inhibitors. In: Viral Polymerases: Structure, Functions and Roles as Antiviral Drug Targets, Gupta, S.P. (Ed.). Academic Press, London, pp: 155-179.
  15. Singh, S., B. Shaik and S.P. Gupta, 2017. In silico Design of Carbonic Anhydrase Inhibitors as Antitumor Drugs. In: Advances in Studies on Enzyme Inhibitors as Drugs, Volume 1: Anticancer and Antiviral Drugs, Gupta, S.P. (Ed.). Chapter 7, Nova Science Publishers Inc., New York, USA., ISBN: 978-1-53610-504-9, pp: 169-190.
  16. Sharma, A., S.P. Gupta, A.A. Siddiqui and N. Sharma, 2017. HCV NS3/4A protease and its emerging inhibitors. J. Analyt. Pharm. Res., 4: 1-9.
  17. Sharma, A. and S.P. Gupta, 2017. Fundamentals of Viruses and Their Proteases. In: Viral Proteases and Their Inhibitors, Gupta, S.P. (Ed.). Academic Press, London, ISBN: 978-0-12-809712-0, pp: 1-24.
  18. Shaik, B., V. Agrawal, S.P. Gupta and U. Menon, 2017. Quantitative structure-activity relationship and docking studies on a series of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Lett. Drug Des. Discov., 14: 10-27.
    CrossRef  |  Direct Link  |  
  19. Shaik, B., S.P. Gupta and V.K. Agrawal, 2017. Design and Development of Tyrosine Kinase Inhibitors as Anticancer Drugs. In: Advances in Studies on Enzyme Inhibitors as Drugs, Volume 1: Anticancer and Antiviral Drugs, Gupta, S.P. (Ed.). Chapter 6, Nova Science Publishers Inc., New York, USA., ISBN: 978-1-53610-504-9, pp: 139-168.
  20. Shaik, B., O. Deeb, V.K. Agrawal and S.P. Gupta, 2017. QSAR and molecular docking studies on a series of cinnamic acid analogues as epidermal Growth Factor Receptor (EGFR) inhibitors. Lett. Drug Des. Discov., 14: 83-95.
    CrossRef  |  Direct Link  |  
  21. Shaik, B. and S.P. Gupta, 2017. QSAR and molecular docking studies on a series of oxazolidinones as HIV-1 protease inhibitors. J. Applied Biopharm. Pharmacod., 5: 30-36.
  22. Sakkiah, S., G.P. Cao, S.P. Gupta, S.J. Park and K.W. Lee, 2017. Overview of the structure and function of protein kinases. Curr. Enzym. Inhibn., 13: 81-88.
    CrossRef  |  Direct Link  |  
  23. Patil, V.M., S.P. Gupta and N. Masand, 2017. QSAR studies on tyrosine kinase inhibitors. Curr. Enzym. Inhibn., 13: 139-169.
  24. Patil, V.M., N. Masand, K.R. Gurukumar, M. Chudayeu, S.P. Gupta, S. Samanta and N. Kaushik-Basu, 2017. QSAR and molecular docking directed synthesis and preliminary evaluation of novel non-nucleoside HCV NS5B polymerase inhibitors. Anti-Infect. Agents, 15: 52-56.
    Direct Link  |  
  25. Patil, V.M. and S.P. Gupta, 2017. Studies on Picornaviral Proteases and their Inhibitors. In: Viral Proteases and their Inhibitors, Gupta, S.P. (Ed.). Academic Press, London, ISBN: 978-0-12-809712-0, pp: 263-315.
  26. Patil, V.M. and S.P. Gupta, 2017. Neuraminidase Inhibitors: From Research Tools to Drug Candidates. In: Advances in Studies on Enzyme Inhibitors as Drugs, Volume 1, Gupta, S.P. (Ed.). Nova Science Publishers, Hauppauge, NY, USA., pp: 237-286.
  27. Masand, N., S.P. Gupta, R.L. Khosa and V.M. Patil, 2017. Heterocyclic secretase inhibitors for the treatment of Alzheimer's disease: An overview. Cent. Nerv. Syst. Agents Med. Chem., 17: 3-25.
    CrossRef  |  
  28. Hadjipavlou-Litina, D. and S.P. Gupta, 2017. Design and Development of Inhibitors of Herpes Viral Proteases and their SAR and QSAR. In: Viral Proteases and Their Inhibitors, Gupta, S.P. (Ed.). Academic Press, London, ISBN: 978-0-12-809712-0, pp: 439-466.
  29. Gupta, S.P., B. Shaik and Y.S. Prabhakar, 2017. Advances in Studies on Adenovirus Proteases and their Inhibitors. In: Viral Proteases and their Inhibitors, Gupta, S.P. (Ed.). Academic Press, London, ISBN: 978-0-12-809712-0, pp: 59-75.
  30. Gupta, S.P., B. Shaik and V.K. Agrawal, 2017. Specificity of binding in protein kinases. Curr. Enzyme Inhib., 13: 89-98.
    CrossRef  |  Direct Link  |  
  31. Singh, N., B. Shaik, N. Agrawal, V.K. Agrawal and S.P. Gupta, 2016. QSAR and molecular modeling studies on a series of indole-based pyridone analogues as HCV NS5B polymerase inhibitors. Lett. Drug Des. Discov., 13: 757-770.
    CrossRef  |  Direct Link  |  
  32. Sharma, S., B. Shaik, S.P. Gupta and V.K. Agrawal, 2016. Quantitative structure-activity relationship and docking studies on a series of substituted acyl(thio)ureas and thiadiazolo[2,3-a]pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase. J. Applied Biopharm. Pharmacol., 4: 1-12.
  33. Sharma, A., S.P. Gupta, A.A. Siddiqui and N. Sharma, 2016. A quantitative structure-activity relationship study on a indo-2-yl derivatives as anti-HCV agents. Der Pharm. Chem., 8: 15-61.
  34. Patil, V.M., N. Masand and S.P. Gupta, 2016. HCV inhibitors: Role of compounds from botanical sources. Curr. Topic Med. Chem., 16: 1402-1409.
    Direct Link  |  
  35. Patil, V.M., N. Masand and S.P. Gupta, 2016. Genius in silico screening technology for HCV drug discovery. Curr. Drug Discov. Technol., 13: 189-198.
  36. Patil, V.M. and S.P. Gupta, 2016. Studies on chloride channels and their modulators. Curr. Top. Med. Chem., 16: 1862-1876.
    Direct Link  |  
  37. Gupta, S.P., H. Kumar and B. Shaik, 2016. Quantitative structure-activity relationship studies on nitric oxide synthase inhibitors. Curr. Enzyme Inhib., 12: 67-80.
    CrossRef  |  Direct Link  |  
  38. Ahmad, I., B. Shaik, N. Singh, V.K. Agrawal, K. Anita and S.P. Gupta, 2016. Quantitative structure-activity relationship and molecular modeling studies on a series of H+-K+-ATPase inhibitors. J. Applied Biopharmaceut. Pharmacokinet., 4: 20-39.
    CrossRef  |  Direct Link  |  
  39. Gupta, S.P., 2015. Quantitative structure-activity relationship studies on hydroxamic acids: A very fascinating family of chemicals with wide spectrum of activities. Chem. Rev., 11: 6427-6490.
    CrossRef  |  
  40. Anitha, K., N. Singh, B. Shaik, I. Ahmad, V.K. Agrawal and S.P. Gupta, 2015. QSAR and docking studies on 1,1-dioxo-2H-benzothiadiazines acting as HCV NS5B polymerase inhibitors. J. Mod. Med. Chem., 3: 49-68.
  41. Patil, V.M., S.P. Gupta and N. Masand, 2014. QSAR analysis of some heterocyclic compounds as HCV NS5B polymerase inhibitors. J. Eng. Sci. Manage. Educ., 7: 215-219.
  42. Patil, V.M., N. Masand and S.P. Gupta, 2014. Role of Proteases in the Management of Hepatitis C Virus. In: Proteases in Health and Diseases, Chakraborthy, S. and N.S. Dhalla (Eds.). Springer, New York, ISBN: 978-1-4614-9233-7, pp: 335-360.
  43. Patil, V.M. and S.P. Gupta, 2014. Oncolytic Viruses and Histone Deacetylase Inhibitors. In: Cancer-Causing Viruses and Their Inhibitors, Gupta, S.P. (Ed.). 1st Edn., CRC Press, USA., ISBN-13: 978-1466589773, pp: 437-466.
  44. Kaur, P.K., S.P. Gupta, V.K. Agrawal, B. Sheikh and N. Singh, 2014. Quantitative structure-activity relationship and molecular modeling studies on a series of influenza neuraminidase inhibitors with cyclohexene scaffold. J. Eng. Sci. Manage. Educ., 7: 220-227.
  45. Gupta, S.P., 2014. Some basic aspects of 2D QSAR, the root of QSAR. J. Eng. Sci. Manage. Educ., 7: 167-169.
  46. Gupta, S.P., 2014. Cancer-Causing Viruses and their Inhibitors. 1st Edn., CRC Press, USA., ISBN-13: 978-1466589773, Pages: 511.
  47. Gupta, S.P. and V. Gautam, 2014. Caner Causing Viruses: An Introduction. In: Cancer-Causing Viruses and Their Inhibitors, Gupta, S.P. (Ed.). 1st Edn., CRC Press, USA., ISBN-13: 978-1466589773, pp: 1-20.
  48. Gupta, S., N. Agarwal, V.K. Agarwal, S.P. Gupta and B. Shaik, 2014. A quantitative structure-activity relationship and molecular modeling study on a series of indole-5-carboxamides acting as hepatitis C virus inhibitors. Int. J. Chem. Model., 6: 429-460.
  49. Bharti, V.D., S.P. Gupta and H. Kumar, 2014. A quantitative structure-activity relationship (QSAR) study on a few series of potent, highly selective inhibitors of nitric oxide synthase. Indian J. Biochem. Biophys., 51: 29-36.
  50. Bajpai, A., N. Agarwal, V.K. Agrawal, B. Shaik and S.P. Gupta, 2014. Quantitative structure-activity relationship and molecular modeling studies on a series of hydroxamate analogues acting as HDAC inhibitors. J. Mod. Med. Chem., 2: 43-59.
  51. Bajpai, A., N. Agarwal, V. Srivastava, A. Mishra and S.P. Gupta, 2014. A comparative 2D QSAR study on a series of hydroxamic acid-based histone deacetylase inhibitors vis-à-vis comparative molecular field analysis and comparative molecular similarity indices analysis. Indian J. Biochem. Biophys., 51: 244-252.
  52. Thaler, F., V.M. Patil and S.P. Gupta, 2013. Hydroxamic Acids as Histone Deacetylase Inhibitors. In: Hydroxamic Acids: A Unique Family of Chemicals with Multiple Biological Activities, Gupta, S.P. (Ed.). Springer, Berlin, Heidelberg, ISBN: 978-3-642-38110-2, pp: 99-152.
  53. Sharma, A., S.P. Gupta and A.A. Siddiqui, 2013. A QSAR study on a series of thiourea derivatives acting as anti-hepatitis C virus agents. Indian J. Biochem. Biophys., 50: 278-283.
  54. Patil, V.M. and S.P. Gupta, 2013. Structure-Activity Relationship Studies of Hydroxamic Acids as Matrix Metalloproteinase Inhibitors. In: Hydroxamic Acids: A Unique Family of Chemicals with Multiple Biological Activities, Gupta, S.P. (Ed.). Springer, Berlin, Heidelberg, ISBN: 978-3-642-38110-2, pp: 71-98.
  55. Patil, V., S. Gupta, S. Samanta and N. Masand, 2013. Virtual screening of imidazole analogs as potential hepatitis C virus NS5B polymerase inhibitors. Chem. Pap., 67: 236-244.
    CrossRef  |  Direct Link  |  
  56. Pandey, Y. and S.P. Gupta, 2013. Design of some new potent beta-secretase inhibitors based on QSAR and molecular modeling study on a series of hydroxyethylamine derivatives. Lett. Drug Des. Discov., 10: 253-265.
    CrossRef  |  Direct Link  |  
  57. Kumar, V. and S.P. Gupta, 2013. A QSAR and molecular modeling study on a series of 3,4-dihydro-1-isoquinolinamines and thienopyridines acting as nitric oxide synthase inhibitors. Indian J. Biochem. Biophys., 50: 72-79.
  58. Kumar, V. and S.P. Gupta, 2013. In silico design of some potent carbamidine derivatives acting as human nitric oxide synthase inhibitors. Int. J. Chem., 2: 47-54.
  59. Kumar, H., S.P. Gupta, A.A. Siddiqui and V. Kumar, 2013. Advances in design and development of inhibitors of nitric oxide synthases. Curr. Enzyme Inhibition, 9: 117-141.
    Direct Link  |  
  60. Kumar, H., A.A. Siddiqui and S.P. Gupta, 2013. A quantitative structure-activity relationship study on some imidazoles and 2-aminopyridines acting as Nitric Oxide Synthase (NOS) inhibitors. Lett. Drug Des. Discov., 10: 666-674.
    Direct Link  |  
  61. Gupta, S.P., S. Samanta, N. Masand and V.M. Patil, 2013. k nearest neighbor-molecular field analysis on human HCV NS5B polymerase inhibitors: 2,5-disubstituted imidazo [4,5-c] pyridines. Med. Chem. Res., 22: 330-339.
    CrossRef  |  Direct Link  |  
  62. Gupta, S.P. and A. Sharma, 2013. Chemistry of Hydroxamic Acids. In: Hydroxamic Acids: A Unique Family of Chemicals with Multiple Biological Activities, Gupta, S.P. (Ed.). Springer, Berlin, Heidelberg, ISBN: 978-3-642-38110-2, pp: 1-18.
  63. Gupta, S., S.P. Gupta and N. Agarwal, 2013. A quantitative structure-activity relationship and molecular modeling study on a series of pyrimidines. J. Proteins Proteomics, 4: 191-216.
  64. Anwer, Z. and S.P. Gupta, 2013. A QSAR study on some series of anticancer tyrosine kinase inhibitors. Med. Chem., 9: 203-212.
    Direct Link  |  
  65. Agarwal, N., A. Bajpai, V. Srivastava and S.P. Gupta, 2013. A quantitative structure-activity relationship and molecular modeling study on a series of biaryl imidazole derivatives acting as H+/K+-ATPase inhibitors. Struct. Biol., Vol. 2013. 10.1155/2013/810691 .
    CrossRef  |  
  66. Agarwal, N., A. Bajpai and S. Gupta, 2013. A quantitative structure-activity relationship and molecular modeling study on a series of heteroaryl- and heterocyclyl-substituted imidazo[1,2-a]pyridine derivatives acting as acid pump antagonists. Biochem. Res. Int., Vol. 2013. 10.1155/2013/141469.
    CrossRef  |  
  67. Varshney, J., A. Sharma and S.P. Gupta, 2012. A quantitative structure-activity relationship study on a few series of anti-hepatitis C virus agents. Med. Chem., 8: 491-504.
    Direct Link  |  
  68. Varshney, J., A. Sharma and S.P. Gupta, 2012. A QSAR study on a series of thiophene derivatives acting as anti-HCV agents. Lett. Drug Des. Discov., 9: 389-396.
  69. Vaishali, M.P., K.R. Gurukumar, C. Maksim, P.G. Satya, S. Subeer, M. Neeraj and K.B. Neerja, 2012. Synthesis, in vitro and in silico NS5B polymerase inhibitory activity of benzimidazole derivatives. Med. Chem., 8: 629-635.
    CrossRef  |  Direct Link  |  
  70. Samanta, S., S.P. Gupta, N. Masand, N.K. Basu and V.M. Patil, 2012. Docking directed kNN MFA study of pyrimidine nucleosides as HCV NS5B inhibitors. Int. J. Drug Des. Discov., 3: 809-813.
  71. Patil, V.M., S.P. Gupta, S. Samanta and N. Masand, 2012. 3D-QSAR and docking studies on a series of benzothiadiazine derivatives as genotype 1 HCV polymerase inhibitors. Med. Chem., 8: 1099-1107.
    CrossRef  |  Direct Link  |  
  72. Patil, V.M. and S.P. Gupta, 2012. Quantitative Structure-Activity Relationship Studies on Sulfonamide-Based MMP Inhibitors. In: Matrix Metalloproteinase Inhibitors: Specificity of Binding and Structure-Activity Relationships, Gupta, S.P. (Ed.). Springer, Basel AG, ISBN: 9783034803649, pp: 177-208.
  73. Gupta, S.P., 2012. Quantitative structure-activity relationship studies on Na+, K+-ATPase inhibitors. Chem. Rev., 112: 3171-3192.
    CrossRef  |  Direct Link  |  
  74. Gupta, S.P. and V.M. Patil, 2012. Specificity of Binding with MMPs. In: Matrix Metalloproteinase Inhibitors: Specificity of Binding and Structure-Activity Relationships, Gupta, S.P. (Ed.). Springer, Basel AG, ISBN: 9783034803649, pp: 35-56.
  75. Anwer, Z. and S.P. Gupta, 2012. A QSAR study on a series of pyrrole derivatives acting as lymphocyte-specific kinase (Lck) inhibitors. Med. Chem., 8: 649-655.
    CrossRef  |  Direct Link  |  
  76. Yadav, R.K., S.P. Gupta, P.K. Sharma and V.M. Patil, 2011. Recent advances in studies on hydroxamates as matrix metalloproteinase inhibitors: A review. Curr. Med. Chem., 18: 1704-1722.
    PubMed  |  
  77. Seelam, J., V.S.A. Kumar Satuluri, S.P. Gupta and Z. Anwer, 2011. A QSAR study on a series of simplified digitalis-like compounds acting on Na+, K+-ATPase. Indian J. Biochem. Biophys., 48: 158-163.
  78. Patil, V.M., S.P. Gupta, S. Samanta and N. Masand, 2011. Current perspective of HCV NS5B inhibitors: A review. Curr. Med. Chem., 18: 5564-5597.
    CrossRef  |  Direct Link  |  
  79. Kaushik, S., S.P. Gupta, P.K. Sharma and Z. Anwer, 2011. A QSAR study on some series of HIV-1 integrase inhibitors. Med. Chem., 7: 553-560.
    CrossRef  |  Direct Link  |  
  80. Kaushik, S., S.P. Gupta, P.K. Sharma and Z. Anwer, 2011. A QSAR study on a series of N-methyl pyrimidones acting as HIV integrase inhibitors. Indian J. Biochem. Biophys., 48: 427-434.
  81. Gupta, S.P. and V.M. Patil, 2011. Specificity of Binding of MMPIs with MMPs. In: Advances in Studies on Matrix Metalloproteinase Inhibitors, Gupta, S.P. (Ed.). Birkhauser, Basle, Switzerland.
  82. Gupta, S.P. and P.K. Kaur, 2011. Chloride Channel Blockers: Structure, Functions and Inhibitors. In: Advances in the Studies on Ion Channels and Their Blockers, Gupta, S.P. (Ed.). Springer-Verlag, Berlin-Heidelberg, Germany, pp: 309-339.
  83. Anwer, Z. and S.P. Gupta, 2011. A QSAR study on a series of indolin-2-ones acting as non-receptor Src tyrosine kinase inhibitors. Lett. Drug Des. Discov., 8: 918-925.
    CrossRef  |  Direct Link  |  
  84. Srivastava, V., S.P. Gupta, M.I. Siddiqi and B.N. Mishra, 2010. Molecular docking studies on quinazoline antifolate derivatives as human thymidylate synthase inhibitors. Bioinformation, 4: 357-365.
    PubMed  |  Direct Link  |  
  85. Srivastava, V., S.P. Gupta, M.I. Siddiqi and B.N. Mishra, 2010. 3D-QSAR studies on quinazoline antifolate thymidylate synthase inhibitors by CoMFA and CoMSIA models. Eur. J. Med. Chem., 45: 1560-1571.
    CrossRef  |  
  86. Patil, V.M., S.P. Gupta, S. Samanta and N. Masand, 2010. 3D QSAR kNN-MFA studies on thiouracil derivatives as hepatitis C virus inhibitors. Med. Chem. Res., (In Press) 10.1007/s00044-010-9435-x.
    CrossRef  |  Direct Link  |  
  87. Patil, V.M., S.P. Gupta and S. Samanta, 2010. A QSAR study on some series of Anti-Hepatitis C Virus (HCV) agents. Lett. Drug Des. Discovery, 7: 139-148.
    CrossRef  |  Direct Link  |  
  88. Kaushik, S., S.P. Gupta and P.K. Sharma, 2010. Design and development of anti hepatitis B virus agents. Curr. Med. Chem., 17: 3377-3392.
    PubMed  |  Direct Link  |  
  89. Gupta, S.P., V.M. Patil and S. Samanta, 2010. A 3D-QSAR study on a series of benzimidazole derivatives acting as hepatitis c virus inhibitors: Application of kNN-molecular field analysis. Med. Chem., 6: 87-90.
    CrossRef  |  Direct Link  |  
  90. Arora, P.K., V.M. Patil and S.P. Gupta, 2010. A QSAR study on some series of Anti-Hepatitis B Virus (HBV) agents. Bioinformation, 4: 417-420.
    PubMed  |  Direct Link  |  
  91. Saini, L., S.P. Gupta and V.S.A. Kumar Satuluri, 2009. A QSAR study on some series of sodium and potassium channel blockers. Med. Chem., 5: 570-576.
    CrossRef  |  Direct Link  |  
  92. Kumar Satuluri, V.S.A., J. Seelam and S.P. Gupta, 2009. A quantitative structure-activity relationship study on some series of potassium channel blockers. Med. Chem., 5: 87-92.
    PubMed  |  Direct Link  |  
  93. Naik, M.A., V.S.A. Kumar Satuluri and S.P. Gupta, 2008. QSAR studies on some calcium channel blockers. Lett. Drug Des. Discovery, 5: 307-312.
  94. Kumar Satuluri, V.S.A. and S.P. Gupta, 2008. A QSAR study on some series of ATP-sensitive potassium channel openers. Lett. Drug Des. Discovery, 5: 173-177.
    CrossRef  |  Direct Link  |  
  95. Gupta, S.P., P. Bagaria and V.S.A. Kumar Satuluri, 2008. A quantitative structure-activity relationship study on a novel series of hydroxamic acid analogs acting as matrix metalloproteinase inhibitors. Lett. Drug Des. Discovery, 5: 281-285.
    CrossRef  |  Direct Link  |  
  96. Kumaran, S. and S.P. Gupta, 2007. Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: Piperidine sulfonamide aryl hydroxamic acid analogs. J. Enzyme Inhib. Med. Chem., 22: 23-27.
    PubMed  |  Direct Link  |  
  97. Kumaran, S. and S.P. Gupta, 2007. A quantitative structure-activity relationship study on some novel series of hydroxamic acid analogs acting as matrix metalloproteinase inhibitors. Med. Chem., 3: 167-173.
    PubMed  |  Direct Link  |  
  98. Gupta, S.P., P. Bagaria and V.S. Ashok Kumar Satuluri, 2007. A quantitative structure-activity relationship study on some aryl sulfonyl amido and ureido derivatives acting as matrix metalloproteinase and Clostridium histolyticum collagenase inhibitors. Lett. Drug Des. Discovery, 4: 496-501.
    CrossRef  |  Direct Link  |  
  99. Gupta, S.P., 2007. QSAR studies on zinc-containing metalloproteinase inhibitors. Chem. Rev., 107: 3042-3087.
  100. Gupta, S.P., 2006. QSAR Studies on Calcium Channel Blockers. In: QSAR and Molecular Modeling Studies in Heterocyclic Drugs II, Gupta, S.P. (Eds.). Springer-Verlag, Berlin-Heidelberg, Germany, pp: 251-289.
  101. Gupta, S.P. and S. Kumaran, 2006. Quantitative structure-activity relationship studies on matrix metalloproteinase inhibitors: Piperazine, piperidine and diazepine hydroxamic acid analogs. Asian J. Biochem., 1: 211-223.
    CrossRef  |  Direct Link  |  
  102. Gupta, S.P. and S. Kumaran, 2006. Quantitative structure-activity relationship studies on benzodiazepine hydroxamic acid inhibitors of matrix metalloproteinases and tumor necrosis factor-α converting enzyme. Asian J. Biochem., 1: 47-56.
    CrossRef  |  Direct Link  |  
  103. Gupta, S.P., A. Veerman and P. Bagaria, 2005. Quantitative structure-activity relationship studies on some series of calcium channel blockers. Mol. Divers., 8: 357-363.
    CrossRef  |  PubMed  |  Direct Link  |  
  104. Gupta, S.P., A. Paleti, S.B. Mekapati, A.N. Nagappa and S. Kumaran, 2005. A quantitative structure-activity relationship study on some Na+ and K+ channel blockers: Role of molecular connectivity index. Lett. Drug Des. Discovery, 2: 287-290.
    CrossRef  |  Direct Link  |  
  105. Gupta, S.P. and S. Kumaran, 2005. A quantitative structure-activity relationship study on some series of anthranilic acid-based matrix metalloproteinase inhibitors. Bioorg. Med. Chem., 13: 5454-5462.
    CrossRef  |  PubMed  |  Direct Link  |  
  106. Gupta, S.P. and S. Kumaran, 2005. A quantitative structure-activity relationship study on some aromatic/heterocyclic sulfonamides and their charged derivatives acting as carbonic anhydrase inhibitors. J. Enzyme Inhib. Med. Chem., 20: 251-259.
    PubMed  |  Direct Link  |  
  107. Gupta, S.P., P. Bagaria and S. Kumaran, 2004. A quantitative structure-activity relationship study on a series of Na+, K+-ATPase inhibitors. J. Enzyme Inhib. Med. Chem., 19: 389-393.
    PubMed  |  Direct Link  |  
  108. Gupta, S.P., 2004. Ethics of scientific publications. Natl. Acad. Sci. Lett., 27: 187-192.
  109. Gupta, S.P. and A.N. Nagappa, 2004. Quantitative structure-activity relationship studies on cholecystokin antagonists. Med. Chem. Rev. Online, 1: 349-350.
    CrossRef  |  Direct Link  |  
  110. Kumar, D. and S.P. Gupta, 2003. A quantitative structure-activity relationship study on some matrix metalloproteinase and collagenase inhibitors. Bioorg. Med. Chem., 11: 421-426.
    Direct Link  |  
  111. Gupta, S.P., V. Maheswaran, V. Pande and D. Kumar, 2003. A comparative quantitative structure-activity relationship study on carbonic anhydrase and matrix metalloproteinase inhibition by sulfonylated amino acid hydroxamates. J. Enzyme Inhib. Med. Chem., 18: 7-13.
    PubMed  |  
  112. Gupta, S.P., D. Kumar and S. Kumaran, 2003. A quantitative structure-activity relationship study of hydroxamate matrix metalloproteinase inhibitors derived from fuctionalized 4-aminoprolines. Bioorg. Med. Chem., 11: 1975-1981.
    PubMed  |  
  113. Gupta, S.P., 2003. QSARs of renin inhibitors. Min. Rev. Med. Chem., 3: 159-165.
  114. Gupta, S.P., 2003. QSARs of carbonic anhydrase inhibitors. Prog. Drug Res., 60: 171-204.
  115. Gupta, S.P., 2003. Quantitative structure-activity relationships of renin inhibitors. Min. Rev. Med.Chem., 3: 315-321.
    PubMed  |  
  116. Gupta, S.P. and S. Kumaran, 2003. A quantitative structure activity relationship study on clostridium histolyticum collagenase inhibitors roles of electrotopological state indices. Bioorg. Med. Chem., 11: 3065-3071.
    CrossRef  |  
  117. Gupta, S.P. and A.N. Nagappa, 2003. Design and development of integrase inhibitors as anti-HIV agents. Curr. Med. Chem., 10: 1779-1794.
    PubMed  |  
  118. Gupta, S.P. A.N. Mathur, A.N. Nagappa and D. Kumar and S. Kumaran, 2003. A quantitative structure-activity relationship study on a novel class of calcium entry blockers: 1-[4-(Aminoalkoxy)phenyl]sulfonyl]indolizines. Eur. J. Med. Chem., 38: 867-873.
    PubMed  |  
  119. Gupta, S.P., 2002. Quantitative structure-activity relationship studies on cholecystokinin antagonists. Curr. Pharm. Des., 8: 111-124.
    PubMed  |  
  120. Gupta, S.P., 2002. Advances in QSAR studies of HIV-1 reverse transcriptase inhibitors. Prog. Drug. Res., 58: 223-264.
  121. Gupta, S.P., 2002.. Electronic Effects of Substituents in Oxidation Reactions. In: Advances in Quantitative Structure Property Relationships, Charton, M. and B.I. Charton, (Eds.). Elsevier Science, Netherlands, pp: 1-26.
  122. Mekapati, S.B., R. Sivakumar and S.P. Gupta, 2001. Quantitative structure-activity relationship of some HIV-1 protease inhibitors: A fujita-ban type analysis. J. Enzyme Inhib., 16: 185-197.
    PubMed  |  
  123. Gupta, S.P., 2001. QSARs of antianginal drug. Prog. Drug Res., 56: 121-153.
  124. Gayathri, P., V. Pande, R. Sivakumar and S.P. Gupta, 2001. A quantitative structure-activity relationship study on some HIV-1 protease inhibitors using molecular connectivity index. Bioorg. Med. Chem., 9: 3059-3063.
    CrossRef  |  
  125. Gupta, S.P., 2000. QSARs of cardiotonic agents. Prog. Drug Res., 55: 235-282.
  126. Sinha, J., A. Kurup and S.P. Gupta, 1999. Quantitative structure-activity relationship study on some nonpeptidal cholecystokinin antagonists. Bioorg. Med. Chem., 7: 1127-1130.
    CrossRef  |  
  127. Gupta, S.P., M.S. Babu and N. Kaw, 1999. Quantitative structure-activity relationships of some HIV-protease inhibitors. J. Enzyme Inhib., 14: 109-123.
    PubMed  |  
  128. Gupta, S.P., 1999. QSARs of antihypertensive agents. Prog. Drug Res., 53: 53-87.
  129. Gupta, S.P. and M.S. Babu, 1999. Quantitative structure-activity relationship studies on cyclic cyanoguanidines acting as HIV-1 protease inhibitors. Bioorg. Med. Chem., 7: 2549-2553.
    CrossRef  |  
  130. Garg, R., S.P. Gupta, H. Gao, M.S. Babu, A.K. Debnath and C. Hansch, 1999. QSAR studies on anti HIV-1 drugs. Chem. Rev., 99: 3525-3601.
  131. Gupta, S.P., M.S. Babu, R. Garg and S. Sowmya, 1998. Quantitative structure-activity relationship studies on cyclic urea-based HIV protease inhibitors. J. Enzyme Inhib., 13: 399-407.
    PubMed  |  
  132. Gupta, S.P., M.S. Babu and S. Sowmya, 1998. A quantitative structure-activity relationship study on some sulfolanes and arylthiomethanes acting as HIV-1 protease inhibitors. Bioorg. Med. Chem., 6: 2185-2192.
    CrossRef  |  
  133. Gupta, S.P., 1998. QSARs of antiarrhythmic agents. Curr. Pharm. Des., 4: 455-468.
  134. Gupta, S.P. and A. Paleti, 1998. Quantitative structure-activity relationship studies on some nonbenzodiazepine series of compounds acting at the benzodiazepine receptor. Bioorg. Med. Chem., 6: 2213-2218.
    CrossRef  |  
  135. Aggarwal, D., R.N. Saha and S.P. Gupta, 1998. A quantitative structure-activity relationship study on 3-hydroxy-3-methylglutaryl-coenzyme a reductase inhibitors. J. Pharm. Dyn., 11: 591-599.
  136. Paleti, A. and S.P. Gupta, 1997. Quantitative structure-activity relationship studies on some nonbenzodiazepines binding to benzodiazepine receptor. Quant. Struct.-Act. Relat., 16: 367-371.
    CrossRef  |  
  137. Gupta, S.P. and A. Paleti, 1997. Quantitative structure-activity relationship studies on nonbenzodiazepines binding to benzodiazepine receptors. Proc. Indian Natl. Sci. Acad., Sec. A, 63: 365-381.
  138. Garg, R., A. Kurup and S.P. Gupta, 1997. Quantitative structure-activity relationship studies on some acyclouridine derivatives acting as anti-HIV-1 drugs. Quant. Struct-Act. Relat., 16: 20-24.
    CrossRef  |  
  139. Garg, R. and S.P. Gupta, 1997. Quantitative structure-activity relationship studies on some viral reverse transcriptase inhibitors acting as anti-HIV-1 agents. J. Enzyme Inhib., 11: 171-181.
    PubMed  |  
  140. Garg, R. and S.P. Gupta, 1997. Quantitative structure-activity relationship studies on some anti-human-immunodeficiency-virus-1 (anti-HIV-1) drugs: Viral reverse transcriptase inhibitors. J. Enzyme Inhibn., 12: 1-12.
    PubMed  |  
  141. Gupta, S.P. and R. Garg, 1996. Quantitative structure-activity relationship studies on anti-HIV-1 TIBO derivatives as inhibitors of viral reverse transcriptase. J. Enzyme Inhib., 11: 23-32.
    PubMed  |  
  142. Gupta, S.P. and A. Paleti, 1996. Quantitative structure-activity relationship studies on benzodiazepine receptor binding on some nonbenzodiazepine series of ligands. Quant. Struct.-Act. Relat., 15: 12-16.
    CrossRef  |  
  143. Gupta, S.P. S.N. Anil and A. Kurup, 1996. A quantitative structure-activity relationship study on dna-directed alkylating agents. Indian J. Biochem. Biophys., 33: 234-236.
    PubMed  |  
  144. Gupta, S.P., V. Mulchandani, S.R. Das, A. Subbiah and D.N. Reddy, 1995. A quantitative structure-activity study on some cholecystokinin antagonists, Quant. Struct-Act. Relat., 14: 437-443.
  145. Gupta, S.P., 1995. Recent advances in benzodiazepine receptor binding studies. Prog. Drug Res., 45: 67-106.
  146. Gupta, S.P., 1994. Recent advances in structure-activity relationship studies on benzodiazepine receptor binding. Indian J. Chem., 33: 105-112.
  147. Gupta, S.P., 1994. Quantitative structure-activity relationship studies on anticancer drugs. Chem. Rev., 94: 1507-1551.
    CrossRef  |  
  148. Gupta, S.P. and V. Mulchandani, 1993. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: Investigation of interaction model. Indian J. Biochem. Biophys., 30: 181-186.
    PubMed  |  
  149. Gupta, S.P., R.N. Saha and V. Mulchandani, 1992. Quantitative structure-activity relationship studies on benzodiazepine receptor binding: recognition of active sites. J. Molec. Recogn., 5: 75-80.
    PubMed  |  
  150. Gupta, S.P., 1992. Mechanism of chemical carcinogenesis. Indian J. Chem., 31: 526-532.
  151. Gupta, S.P. and R.N. Saha, 1992. A QSAR Study on Some Cholecystokinin Antagonists. In: QSAR in Design of Bioactive Compounds, Kuchar, M. (Ed.). J.R. Prous Science Publishers, Spain, pp: 285-299.
  152. Saha, R.N., J. Meera, N. Agrawal and S.P. Gupta, 1991. QSAR studies on benzodiazepine receptor binding of purines and amino acid derivatives. Drug Des. Deliv., 7: 219-226.
    Direct Link  |  
  153. Gupta, S.P., 1991. QSAR studies on local anesthetics. Chem. Rev., 91: 1109-1119.
  154. Gupta, S.P., 1991. QSAR in design of bioactive compounds. J. Scient. Indus. Res., 50: 301-310.
  155. Gupta, S.P., 1991. Discriminant analysis of carcinogenic nature of aromatic amines. Indian J. Chem., 30: 122-126.
  156. Gupta, S.P., R.N. Saha and P. Singh, 1990. A quantitative structure-activity relationship study on some potential neuroleptic agents. Drug Des. Del., 6: 41-47.
  157. Gupta, S.P., R.N. Saha and J.K. Gupta, 1990. A quantitative structure-activity relationship study for local anesthetic activity of mono and diaryl-2-quinuclidinylcarinols. Res. Commun. Chem. Pathol. Pharmacol., 67: 297-300.
  158. Gupta, S.P., J.K. Gupta and R.N. Saha, 1990. A quantitative structure-activity relationship study on inhibitory effects of local anesthetics on batrachotoxin-elicited sodium flux and phosphoinositide breakdown and batrachotoxin binding to sodium channels. Drug Des. Deliv., 6: 131-135.
    PubMed  |  
  159. Gupta, S.P. and R.N. Saha, 1990. A QSAR Study on Some Cholecystokinin Antagonists. In: QSAR in Design of Bioactive Compounds, Kuchar, M. and J.R. Prous (Ed)., Science Publishers, Spain, pp: 285-299.
  160. Gupta, S.P. and J.K. Gupta, 1990. Quantitative structure-activity relationship study on some 5-Lipoxygenase inhibitors. J. Enzyme Inhib., 3: 179-188.
    PubMed  |  
  161. Gupta, S.P., R.N. Saha, J.K. Gupta and P. Singh, 1989. A quantitative structure-activity relationship study on some pyrazolo[4,5, c]- quinolines acting as inhibitors of benzodiazepine receptor binding. Res. Commun. Chem. Pathol. Pharmacol., 65: 119-122.
    PubMed  |  
  162. Gupta, S.P., J.K. Gupta, A.N. Nagappa, V. Jagannathan and D. Gangwal, 1989. A QSAR study on renin inhibitors, Drug Des. Deliv., 5: 73-80.
    PubMed  |  
  163. Gupta, S.P., 1989. QSAR studies on drugs acting at central nervous system. Chem. Rev., 89: 1765-1800.
    CrossRef  |  
  164. Babbar, R., J.K. Gupta and S.P. Gupta, 1989. Quantitative structure-activity relationship study on some dihydropteridine reductase inhibitors. J. Enzyme Inhibn., 2: 231-237.
    PubMed  |  
  165. Gupta, S.P., C. Garg and J.K. Gupta, 1988. A Structure-activity relationship study on papaverine analogs. Res. Commun. Chem. Pathol. Pharmacol., 61: 265-268.
    PubMed  |  
  166. Gupta, S.P., Y.S. Prabhakar and P. Singh, 1987. Quantitative structure-activity relationship studies on prostaglandin synthetase inhibitors. Curr. Sci., 56: 1090-1092.
  167. Gupta, S.P., A. Ray, A. Handa, Y.S. Prabhakar and D. Aggarwal, 1987. Quantitative structure-activity relationship study on amsacrine derivatives. Res. Commun. Chem. Pathol. Pharmacol., 58: 85-95.
    PubMed  |  
  168. Gupta, S.P., A. Handa and D.G. Shewade, 1987. A Comparative study on the mechanism of inhibition of serine proteases by benzamidines based on quantitative structure-activity relationship studies. Arzneim. Forsch., 37: 47-50.
    PubMed  |  
  169. Gupta, S.P., 1987. QSAR studies on enzyme inhibitors. Chem. Rev., 87: 1183-1253.
    CrossRef  |  
  170. Prabhakar, Y.S., S.P. Gupta and A. Ray, 1986. Effect of molecular size on the activity of adriamycin analogues: A quantitative structure-activity relationship study. J. Pharmacobiodyn., 9: 61-67.
    PubMed  |  
  171. Gupta, S.P., P. Tayal and P. Singh, 1986. Molecular connectivity in Huckel's molecular orbital theory. Commun. Math. Chem., 19: 53-65.
  172. Gupta, S.P. and M.K. Sharma, 1986. Molecular connectivity in huckel's molecular orbital theory II. Parameterization of resonance rntegral, Commun. Math. Chem., 21: 123-131.
  173. Takle, H., N. Olagappan and S.P. Gupta, 1985. Conformational analysis of methotrexate. Res. Commun. Chem. Pathol. Pharmacol., 50: 233-243.
    PubMed  |  
  174. Prabhakar, Y.S., A. Handa and S.P. Gupta, 1985. Quantitative correlations of biological activities of dactinomycin analogs and methotrexate derivatives with van der Waals volume. Arzneimittelforschung, 35: 1030-1033.
    PubMed  |  
  175. Prabhakar, Y.S. and S.P. Gupta, 1985. A quantitative structure-activity relationship study on angiotensin converting enzyme inhibitors. An investigation of hydrophobic interaction in inhibition mechanism. Indian J. Biochem. Biophys., 22: 318-320.
  176. Gupta, S.P., D.G. Shewade, C. Garg, A. Handa and Y.S. Prabhakar, 1985. A quantitative analysis of dependence of platelet aggregation inhibition and hypotensive activities of dihydropyridazinone derivatives on molecular size. Indian J. Biochem. Biophys., 22: 122-125.
    PubMed  |  
  177. Gupta, S.P. and Y.S. Prabhakar, 1985. Importance of van der Waals Volume in QSAR studies for drugs. J. Sci. Ind. Res., 44: 189-198.
  178. Prabhakar, Y.S., A. Handa and S.P. Gupta, 1984. Correlation of biological activities of mesoionic and benz-fused mesoionic xanthine analogs with van der Waals volume and molecular connectivity. J. Pharmacobiodyn., 7: 366-371.
    PubMed  |  
  179. Gupta, S.P., Y.S. Prabhakar and A. Handa, 1984. QSAR Studies on Thrombin Inhibitors: Derivatives of N-Substituted L-Arginine. In: QSAR in Design of Bioactive Compounds, Kuchar, M., (Ed.). J.R. Prous Science Publishers, Spain, pp: 175-186.
  180. Handa, A., M.C. Bindal, Y.S. Prabhakar and S.P. Gupta, 1983. Dependence of anaesthetic activity on molecular polarizability and van der Waals volume. Indian J. Biochem. Biophys., 20: 318-320.
    PubMed  |  
  181. Gupta, S.P., Y.S. Prabhakar and A. Handa, 1983. QSAR studies on 4-hydroxyguinoline-3-carboxylic acids as inhibitors of cell respiration using molecular connectivity and van dar Waals volume. Res. Commun. Chem. Pathol. Pharmacol., 42: 455-562.
  182. Gupta, S.P., P. Singh and M.C. Bindal, 1983. QSAR studies on hallucinogens. Chem. Rev., 83: 633-649.
    CrossRef  |  
  183. Gupta, S.P., A. Handa, M.C. Bindal and P. Singh, 1983. QSAR studies on psychotomimetic phenylalkylamines. Arzneimittelforschung, 33: 1089-1090.
    PubMed  |  
  184. Gupta, S.P., P. Singh and M.C. Bindal, 1982. Effect of molecular size on serotonin receptor binding affinity of hallucinogenic phenylalkylamines. Il. Farmaco, Ed. Sci., 37: 566-570.
  185. Gupta, S.P., P. Singh and M.C. Bindal, 1982. Effect of molecular size on inhibition of synaptosome dopamine uptake by antihistaminic pheniramines. Indian J. Biochem. Biophys., 19: 143-144.
    PubMed  |  
  186. Gupta, S.P., P. Singh and M.C. Bindal, 1982. Dependence of antibacterial activities on van der Waals volume. Indian J. Biochem. Biophys., 19: 370-371.
    PubMed  |  
  187. Gupta, S.P., P. Singh and M.C. Bindal, 1982. A quantitative correlation of electronic structure with carcinogenic activity of tricycloquinazolines. Indian J. Biochem. Biophys., 19: 225-227.
    PubMed  |  
  188. Gupta, S.P., M.C. Bindal and P. Singh, 1982. Quantitative structure-activity studies on hallucinogenic mescaline analogs using modified first order valence connectivity. Arzneimittelforschung, 32: 1223-1225.
    PubMed  |  
  189. Bindal, M.C., P. Singh and S.P. Gupta, 1982. Structure-activity studies on hallucinogenic phenylalkylamines using Fujita-Ban approach. Arzneimittelforschung, 32: 719-721.
    PubMed  |  
  190. Kumar, K., M.C. Bindal, P. Singh and S.P. Gupta, 1981. Effect of molecular size on carbonic anhydrase inhibition by sulfonamides. Int. J. Quantum Chem., 20: 123-129.
    CrossRef  |  
  191. Gupta, S.P., P. Singh and M.C. Bindal, 1981. Structure-activity studies on LSD analogs using van der Waals volume. Eur. J. Med. Chem., 16: 446-448.
  192. Gupta, S.P., P. Singh and M.C. Bindal, 1981. Correlation of inhibitory activity of tryptamine derivatives on serotonin uptake in thrombocyte with van der Waals volume. Arzneimittelforschung, 31: 2053-2055.
    PubMed  |  
  193. Bindal, M.C., Y.M. Chopra, P. Singh and S.P. Gupta, 1981. Correlation on sulfhydryl reactivity of unsaturated acylphenoxyacetic acids with electronic parameters. Indian J. Pharm. Sci., 43: 47-49.
  194. Bindal, M.C., P. Singh and S.P. Gupta, 1981. Correlation of toxicity and pyretogenic activity of lysergamides with van der Waals volume. Indian J. Biochem. Biophys., 18: 164-165.
    PubMed  |  
  195. Gupta, S.P., P. Singh and M.C. Bindal, 1980. Effect of molecular size on insecticidal activity of dinitrophenols and alkyl thiocyanates. Indian J. Chem., 19B: 322-323.
  196. Bindal, M.C., P. Singh, R.P. Bhatnagar and S.P. Gupta, 1980. The relationship of vasodilator activity of adenosine analogs with molecular connectivity and van der Waals volume. Arzneimittelforschung, 30: 924-928.
    PubMed  |  
  197. Bindal, M.C., P. Singh and S.P. Gupta, 1980. Quantitative correlation of anesthetic potencies of halogenated hydrocarbons with boiling point and molecular connectivity. Arzneimittelforschung, 30: 234-236.
    PubMed  |  
  198. Bhatnagar, R.P., P. Singh and S.P. Gupta, 1980. Correlation of van der waals volume with boiling point, solubility and molar refraction. Indian J. Chem., 19B: 780-783.
  199. Singh, P. and S.P. Gupta, 1979. Quantitative correlation between the electronic structure and diuretic activity of azanapthalene derivatives. Indian J. Med. Res., 69: 804-808.
    PubMed  |  Direct Link  |  
  200. Gupta, S.P., R.P. Bhatnagar, P. Singh and M.C. Bindal, 1979. The relationship of cellular respiration inhibition activity of 7-substituted 4-hydroxyquinoline-3-carboxylic acids with van der waals volume. Res. Comm. Chem. Pathol. Pharmacol., 25: 111-119.
    PubMed  |  Direct Link  |  
  201. Gupta, S.P. and P. Singh, 1979. The relationship of π-binding energy with molecular connectivity in hydrocarbons. Bull. Chem. Soc. Jpn., 52: 2745-2746.
  202. Gupta, S.P. and P. Singh, 1979. A quantitative aspect of charge-transfer phenomenon in the biological activity of hallucinogens, local anesthetics and nicotinic agents. J. Chem. Sci., 88: 171-177.
    CrossRef  |  Direct Link  |  
  203. Singh, P. and S.P. Gupta, 1978. Electronic structure-activity relationships of antibacterial acridines. J. Pharm. Sci., 67: 706-709.
    PubMed  |  Direct Link  |  
  204. Gupta, S.P. and P. Singh, 1978. Theoretical approach to design of some highly active carbamate herbicides. Indian J. Chem., 16B: 411-414.
  205. Gupta, S.P. and P. Singh, 1978. Structure-activity study of anthelmintic analogs of dichlorves. Indian J. Chem., 16B: 803-806.
  206. Gupta, S.P. and P. Singh, 1978. Scope of molecular connectivity. Index in structure-activity relationship studies. Indian J. Chem., 16B: 709-715.
  207. Gupta, S.P., S.S. Sharma and P. Singh, 1977. Electronic structure and anthelmintic activity of some organophosphorous anthelmintics. Indian J. Chem., 158: 731-733.
  208. Gupta, S.P. and P. Singh, 1977. The electronic structure and intermolecular interaction of nitrogen heterocycles with nucleotide bases. Indian J. Chem., 15B: 1046-1047.
  209. Gupta, S.P. and P. Singh, 1977. π-electron characteristics of some important carboxylic acids. Indian J. Biochem. Biophys., 14: 89-93.
    PubMed  |  Direct Link  |  
  210. Gupta, S.P., 1975. Deduction of IOC-ω technique from orthogonal atomic orbital basis. Indian J. Chem., 13: 717-718.
  211. Gupta, S.P. and P. Singh, 1975. SCF-MO calculation of the ground state properties of the base component of nucleic acids. Indian J. Chem., 13: 668-672.
  212. Gupta, S.P. and G. Govil, 1975. Molecular orbital studies on the conformation of phospholipids II. Preferred conformations of hydrocarbon chains and molecular organization in biomembranes. J. Theor. Biol., 51: 13-34.
    PubMed  |  Direct Link  |  
  213. Srivastava, A.K., S.C. Sharma, B. Krishna and S.P. Gupta, 1974. Calculation of polarographic half-wave reduction and oxidation potentials of alternant hydrocarbons. Indian J. Pure Applied Phys., 12: 434-436.
  214. Gupta, S.P., 1973. The modified PPP (Pariser-Parr-Pole) method. Indian J. Phys., 47: 754-756.
  215. Krishna, B., A.K. Srivastava and S.P. Gupta, 1972. A simplified version of IOC-ω Technique. Indian J. Pure Applied Phys., 1020: 481-483.
  216. Gupta, S.P., A.K. Srivastava and B. Krishna, 1972. On the usefulness of Harri's equation in semi-emperical LCAO-M Approximation. J. Phys. B. Atom. Molec. Phys., 51: 250-254.
    Direct Link  |  
  217. Gupta, S.P. and G. Govil, 1972. Molecular orbital studies on the conformation of phopholipids I. EHT calculations on the Polar end. FEBS Lett., 27: 68-70.
    PubMed  |  
  218. Gupta, S.P. and B. Krishna, 1972. The detailed analysis of IOC-ω technique. J. Phys. B. Atom. Molec. Phys., 5: 1101-1103.
  219. Gupta, S.P. and B. Krishna, 1972. ω-type calculations on π-electron systems with inclusion of overlap charges. Part III. π-Bond energies, heats of formation and resonance energies of conjugated hydrocarbons. J. Am. Chem. Soc., 94: 57-60.
  220. Pandey, J.D. and S.P. Gupta, 1971. Theoretical estimation of heats of atomization of conjugated hydrocarbons. Indian J. Chem. Edu., 2: 1-1.
  221. Pandey, J.D. and S.P. Gupta, 1971. Calculation of mobile bond and delocalization energy. J. Phys. Chem., 246: 177-180.
  222. Krishna, B. and S.P. Gupta, 1971. ω-type calculations on π-electron systems with inclusion of overlap charges. Part II. Electron affinities of some alternant hydrocarbons. J. Chem. Soc., 1971: 123-124.
    CrossRef  |  Direct Link  |  
  223. Gupta, S.P. and B. Krishna, 1971. Justification for the use of Harri's self consistent method in Huckel theory. Indian J. Pure Applied Phys., 9: 347-348.
  224. Krishna, B. and S.P. Gupta, 1970. Ionization potential of some alternant hydrocarbons from more simplified version of pople's SCF-MO theory. Indian J. Pure Applied Phys., 8: 750-751.
  225. Krishna, B. and S.P. Gupta, 1970. Calculations of ionization potential of some alternant hydrocarbon molecules and radicals by extended Huckel theory. J. Chem. Soc., 1970: 997-998.
    CrossRef  |  Direct Link  |  
  226. Krishna, B. and S.P. Gupta, 1970. ω-type calculations on π-electron systems with inclusion of overlap charges.Part I. Ionization potentials of some alternant hydrocarbons. J. Am. Chem. Soc., 92: 7247-7248.
  227. Pandey, J.D. and S.P. Gupta, 1969. Cohesive energy, compressibility and infrared eigen frequency of some Alkyl Halide Crystals. Indian J. Chem., 72: 331-333.
  228. Pandey, J.D. and S.P. Gupta, 1968. On Rittner's theory of Alkali Halide molecules. Univ. Allahabad Stu. Chem. Sci., 7: 7-16.